TDP-43 MITOCHONDRIAL LOCALIZATION INHIBITOR FOR THE TREATMENT OF NEUROGENERATIVE DISEASE

COMPOSITIONS AND METHODS FOR REDUCING THE RATE OF TYPE 1 DIABETES

COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3

GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

COMPOSITION

ANTIGEN-SPECIFIC THERAPY FOR AUTOIMMUNE DISEASES

Antigens Derived from Citrullinated 14-3-3 and Uses Thereof in the Diagnosis of Rheumatoid Arthritis

CLEC9A BINDING AGENTS AND USE THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

THERAPEUTIC TREATMENT OF SKIN DISEASE WITH RECOMBINANT COMMENSAL SKIN MICROORGANISMS

Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization

CLEC9A BINDING AGENTS AND USE THEREOF

NOVEL IMMUNOGENIC PEPTIDES

TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS

Peptide

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS

Peptides And Use Thereof For Diagnosing And Treating Antiphospholipid Syndrome

REGULATORY ELEMENTS FOR SCHWANN CELL-SPECIFIC GENE EXPRESSION

Combinations of Modalities for the Treatment of Diabetes

IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS

COMPOSITIONS AND METHODS FOR DIAGNOSING PRIMARY BILIARY CIRRHOSIS

MYELIN OLIGODENDROCYTE GLYCOPROTEIN-SPECIFIC PEPTIDE FOR THE TREATMENT OR PREVENTION OF MULTIPLE SCLEROSIS

FORMULATION FOR DELIVERY OF LUBRICIN GENE

CHIMERIC AUTOANTIBODY RECEPTOR (CAAR) THAT BINDS AUTOANTIBODIES TARGETING THE CENTRAL NERVOUS SYSTEM IN NEUROLOGICAL AUTOIMMUNE DISEASE

PEPTIDE THERAPEUTICS FOR AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

TDP-43 mitochondrial localization inhibitor for the treatment of neurogenerative disease

Methods of use of soluble CD24 for treating lupus nephritis

T-CELL MODULATORY ANTIGEN-PRESENTING POLYPEPTIDES AND METHODS OF USE THEREOF

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

Peptide

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

PROFILING OF RHEUMATOID ARTHRITIS AUTOANTIBODY REPERTOIRE AND PEPTIDE CLASSIFIERS THEREFOR

Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY

Disease treatment drug based on mesenchymal-stem-cell mobilization

IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

METHODS AND COMPOSITIONS FOR ENHANCING FUNCTIONAL MYELIN PRODUCTION

MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES

COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3

MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS

IN VIVO PRODUCTION OF PROTEINS

Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

RECOMBINANT FILAGGRIN POLYPEPTIDES FOR CELL IMPORTATION

ANTIGENIC PEPTIDES DERIVING FROM PCSK2 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

Dosing regimens of PKC activators

Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif

METHODS OF TREATING AUTOIMMUNE DISEASE

Modified ligand-gated ion channels and methods of use

Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems

Immunogenic peptides and their use in immune disorders

FOXP3-binding peptides and uses thereof

Diagnosis and therapy of multiple sclerosis

Methods and compositions for enhancing functional myelin production

COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

IMMUNOSIGNATURES FOR DIFFERENTIAL DIAGNOSIS

Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif

METHODS AND COMPOSITIONS FOR ENHANCING FUNCTIONAL MYELIN PRODUCTION

Ligands Modified by Circular Permutation as Agonists and Antagonists

Modified ligand-gated ion channels and methods of use

Dosing regimens of PKC activators

COMPOSITION

In vivo production of proteins

Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis

FoxP3-binding peptides and uses thereof

PEPTIDE

Detection and treatment of demyelinating diseases

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

TDP-43 mitochondrial localization inhibitor for the treatment of neurogenerative disease

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS

COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES

Recombinant filaggrin polypeptides for cell importation

NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES

METHODS FOR PRODUCING PEPTIDES AND USES THEREOF

METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT

METHODS FOR THE DIAGNOSTIC OF AN AUTOIMMUNE DISEASE

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

Peptide combinations for use in the diagnosis of schizophrenia

Vectors Conditionally Expressing Protein

Modified Polynucleotides for the production of biologics and proteins associated with human disease

Peptide Selection Method

SECRETED PROTEINS

DIAGNOSIS OF A NOVEL AUTOIMMUNE DISEASE

Therapeutic treatment of skin disease with recombinant commensal skin microorganisms

IL-2 variants for the treatment of psoriasis

Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use

COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS

Myelin oligodendrocyte glycoprotein (MOG) peptide

Specific amyloid beta binding peptides and the use of same for treating and diagnosing alzheimer's dementia

Specific A-beta species-binding peptides for the therapy and/or diagnosis of Alzheimer's dementia

Modified ligand-gated ion channels and methods of use

Inflammatory disease diagnosis and methods of treatment using down-regulators of lipopolysaccharide-responsive beige-like anchor

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

In vivo production of proteins

FcRn-TARGETED ANTIGEN FUSION PROTEINS

METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS

Cytokine-based fusion proteins for treatment of immune disorders

Cytokines and neuroantigens for treatment of immune disorders

Anti-inflammatory agents

POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERS

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit

PEPTIDES ASSOCIATED WITH HLA-DR MHC CLASS II MOLECULE AND INVOLVED IN RHEUMATOID ARTHRITIS

Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog

IL-2 peptide derivatives, and uses thereof for the diagnosis and treatment of an autoimmune disease

Ligands modified by circular permutation as agonists and antagonists

Diagnosis and therapy of multiple sclerosis

Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers

Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity

Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2

Ezrin-derived peptides and pharmaceutical compositions thereof

Methods for detecting autoantibodies against a GABA(A) receptor alpha 1 subunit and/or beta 3 subunit in autoimmune seizure and/or encephalitis

Detection of anti-neurochondrin autoantibody in patients with cerebellar ataxia or cerebellitis

Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide

Polymer conjugate

Cyclic citrullinated peptide, rheumatoid arthritis diagnosis composition including the same, rheumatoid arthritis diagnosis method using the peptide or the composition, and method of screening diagnostic marker for rheumatoid arthritis

Methods of using myelin basis protein peptide compositions

Fusion polypeptides comprising mucin-domain polypeptide linkers

Immunogenic peptides and their use in immune disorders

Efficient mucosal vaccination mediated by the neonatal Fc receptor

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Modified polynucleotides for the production of proteins

Methods for the expression of peptides and proteins

Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor

Modified polynucleotides for the production of biologics and proteins associated with human disease

Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide

Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

Synthetic peptides for the treatment of autoimmune diseases

In vivo production of proteins

Myelin oligodendrocyte glycoprotein peptides

Compositions and methods

Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif

Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)

Albumin fusion proteins

BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE

Modified polynucleotides for the production of cosmetic proteins and peptides

Recombinant bacterium and uses thereof

Methods for treating muscle specific receptor kinase (MuSK) myasthenia gravis with the Ig1 domain of MuSK

Cytokine-based fusion proteins for treatment of immune disorders

C1q peptides and uses thereof

Cytokines and neuroantigens for treatment of immune disorders

Modified polynucleotides for the production of proteins

Treatment of amyloidoses using myelin basic protein and fragments thereof

Secreted proteins

Modified epitopes for boosting CD4+ T-cell responses

TIM-3 ligands and methods of modulating immune responses

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

Vectors conditionally expressing protein

Albumin fusion proteins

BIOMARKERS FOR MULTIPLE SCLEROSIS

Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis

Modified polynucleotides for treating protein deficiency

Ligands modified by circular permutation as agonists and antagonists

Modified polynucleotides for treating galactosylceramidase protein deficiency

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

Modified polynucleotides encoding basic helix-loop-helix family member E41

Biomarkers for ankylosing spondylitis

Modified polynucleotides encoding citeD4

CITRULLINATED PEPTIDES FOR DIAGNOSING AND PROGNOSING RHEUMATOID ARTHRITIS

Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator

Methods of using myelin basic protein peptide compositions

Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

Modified polynucleotides encoding septin-4

SOGA polynucleotides and polypeptides and uses thereof

Modified polynucleotides encoding granulysin

Modified polynucleotides encoding apoptosis inducing factor 1

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

Modified polynucleotides encoding aquaporin-5

Molecules specifically binding pancreatic beta cells biomarkers

Glucocorticoid induced leucine zipper mimetics as therapeutic agents in multiple sclerosis

Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide

Fusion polypeptides comprising mucin-domain polypeptide linkers

Ligands modified by circular permutation as agonists and antagonists

Peptides that modulate complex SASPase-FLG2

Combinations of modalities for the treatment of diabetes

Modified polynucleotides for the production of biologics and proteins associated with human disease

Modified polynucleotides for the production of secreted proteins

Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies

Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes

POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERS

POLYPEPTIDES DERIVED FROM ALPHA-1 ANTITRYPSIN AND METHODS OF USE THEREOF

Compositions including I-domain antigen conjugate compounds and methods for treatment of autoimmune disorders

Peptide composition

Compositions for inhibiting immune complex formation in a subject

Biological Materials and Uses Thereof

PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS

Recombinant filaggrin polypeptides for cell importation

Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis

PEPTIDES ASSOCIATED WITH HLA-DR MHC CLASS II MOLECULE AND INVOLVED IN RHEUMATOID ARTHRITIS

BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE

Efficient mucosal vaccination mediated by the neonatal Fc receptor

Composition for treatment of multiple sclerosis

SOGA polynucleotides and polypeptides and uses thereof

Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases

Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis

CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS

Copolymer-1 improvements in compositions of copolymers

Albumin fusion proteins

Method of treating lupus nephritis

Soluble non-depot insulin conjugates and uses thereof

Antibodies to JTT-1 protein and cells secreting such antibodies

Treatment of amyloidoses using myelin basic protein and fragments thereof

METHOD FOR THE EXPRESSION IN PLANT OF THE GLUTAMIC ACID DECARBOXYLASE (GAD65) AND RELATED EXPRESSION VECTORS

G6PC2-Encoded Beta Cell Surface Tags

MCP1-Ig fusion variants

Conjugates comprising mannan and myelin oligodentrocyte glycoprotein (MOG)

Anti-inflammatory agents

Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors

Method for the detection of endometriosis using an ME-2 antigen

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit

Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

Peptidylarginine deiminase (PAD) inhibitors

PEPTIDE ANALOGUES AND CONJUGATES THEREOF

Antiviral Peptide Against Hepatitis C Virus

Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders

Chemoprevention of colorectal cancer by mesalamine/sulfasalazine

Use of modified cells for the treatment of multiple sclerosis

DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES

Albumin fusion proteins

Method of detecting endometriosis in human subjects using SEQ ID No. 9 or an epitope thereof

Immunogenic peptides and their use in immune disorders

Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis

Myelin basic protein peptide composition

Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region

Compositions and Methods for Treating Diseases, Disorders, or Conditions Characterized by Myelin Degeneration, Myelin Deficiency or Loss

Prevention/treatment of ichthyosis vulgaris, atopy and other disorders

PEPTIDES, ANTIBODIES AND FRAGMENTS THEREOF FOR THE TREATMENT AND DIAGNOSTIC OF CELIAC DISEASE

Methods for inhibiting immune complex formation in a subject

COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING PSORIASIS

Secreted proteins

Foxp3 peptide vaccine

Method for detecting endometriosis in a patient sample

Method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy

Methods of diagnosing endometriosis in human subjects using the ME-5 polypeptide

Cytokine-based fusion proteins for treatment of multiple sclerosis

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis

NUCLEIC SEQUENCE AND DEDUCED PROTEIN SEQUENCE FAMILY WITH HUMAN ENDOGENOUS RETROVIRAL MOTIFS, AND THEIR USES

Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)

METHOD FOR IMMUNOADSORPTION BY MEANS OF AUTOANITGENS

Small antiviral peptides against hepatitis C virus

COMPOUND COMPRISING AN AUTOANTIGENIC PEPTIDE AND A CARRIER WITH A MHC BINDING MOTIF

AGENTS AND METHODS FOR DIAGNOSING OSTEOARTHRITIS

METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

gene for diagnosis and treatment of diabetes

Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors

Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease

Parenteral formulations of peptides for the treatment of systemic lupus erythematosus

Method for regulating immune function in primates using the Foxp3 protein

Trimeric IL-1Ra

Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis

Vaccine for House Dust Mite Allergen Using Naked DNA

Amylin derivatives

Albumin Fusion Proteins

Methods and substrates for conducting assays

COMPOSITION AND METHOD FOR TREATING LUPUS NEPHRITIS

Albumin Fusion Proteins

Compositions and methods for diagnosing or treating psoriasis

Antigenic Targets Of Autoimmune Sensorineural Hearing Loss (AISNHL) And Development Of Tests For Diagnosis And Management Of AISNHL

Diagnosis of autoimmune disease

Methods for the directed expansion of epitopes for use as antibody ligands

Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis

Albumin fusion proteins

Methods and compositions involving polymeric immunoglobulin fusion proteins

Measurement of soluble Tweak levels for evaluation of lupus patients

DIABETES GENE

Novel Use of Prrp and Receptor Thereof

Methods and Compositions for Modulating Gluconeogenesis Using PGC-1

Antibodies to JTT-1 protein and cells secreting such antibodies

PEPTIDE SPECIFICITY OF ANTI-MYELIN BASIS PROTEIN AND THE ADMINISTRATION OF MYELIN BASIC PROTEIN PEPTIDES TO MULTIPLE SCLEROSIS PATIENTS

BIOACTIVE PEPTIDES AND UNIQUE IRES ELEMENTS FROM MYELIN PROTEOLIPID PROTEIN PLP/DM20

Diagnosis of cancers and paraneoplastic neurological syndromes with novel human ULIP/CRMP protein

Albumin fusion proteins

Method for the diagnosis and prognosis of demyelinating diseases

Peptide composition

Ra Antigenic Peptides

Substances for preventing and treating autoimmune diseases

SUBSTANCES FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES

Albumin Fusion Proteins

Albumin fusion proteins comprising insulin polypeptides

Albumin Fusion Proteins

Albumin Fusion Proteins

G-CSF-albumin fusion proteins

ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis

Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability

Albumin fusion proteins

MICROARRAY-BASED ANALYSIS OF RHEUMATOID ARTHRITIS MARKERS

Marker Gene for Arthrorheumatism Test

Bi-functional peptides for multiple sclerosis treatment and diagnosis

Identification of self and non-self antigens implicated in autoimmune disease

Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis